The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4) modulator, met its primary endpoint and also demonstrated a statistically significant relationship ...
COLORADO SPRINGS, CO, UNITED STATES, March 25, 2026 /EINPresswire.com/ — Grenova today announced the appointment of Ted Hull as Chief Executive Officer. Hull will ...
Having worked closely with the company and served alongside the leadership team, he is uniquely positioned to lead this next phase of growth.” With the combined capabilities of Grenova’s technologies ...
AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...
BISMARCK — North Dakota’s public water systems have spent several years creating vast inventories of their service lines in an effort to find pipes made of lead, which pose a health threat. Now, ...
Forbes contributors publish independent expert analyses and insights. Serenity Gibbons is a business consultant who covers entrepreneurs. This voice experience is generated by AI. Learn more. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results